RxDoctor Payments Data

Kristen Howard

Family · Indianapolis, INNPI 1821635111

Payments from drug & device makers

$1,423in general payments, 2019–2025

Across 78 payments — averaging $18.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$277
  • Merck$168
  • Alnylam Pharmaceuticals Inc.$159
  • Novo Nordisk$141
  • AstraZeneca$139
  • Amgen$80
  • plus $458 from 11 others

What the payments were for

  • Food & beverage$1,423100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,423 in reported general payments places this provider in the 70th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$25,672
Medicare patients
140
Services billed
331

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban34$25,586
EntrestoSacubitril/Valsartan25$23,561
FarxigaDapagliflozin Propanediol20$12,226
BrilintaTicagrelor11$5,683
Metoprolol Succinate61$623
Atorvastatin Calcium58$597
ClopidogrelClopidogrel Bisulfate44$501
Carvedilol36$268
Furosemide50$247
Torsemide13$152
Losartan Potassium30$123
Lisinopril22$114
Metoprolol Tartrate31$98
Isosorbide Mononitrate ErIsosorbide Mononitrate15$85
Amlodipine Besylate36$79

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$277$25,58634 claims
NovartisEntresto$63$23,56125 claims
AstraZenecaFarxiga, Brilinta$139$17,91031 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,392 family providers in Indiana.

Other family in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →